• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

情感体验和抗精神病药物治疗的精神病患者 D2 受体占有率的评估:一项经验抽样研究。

Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.

机构信息

Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Center, Maastricht, The Netherlands.

出版信息

J Clin Psychiatry. 2011 Oct;72(10):1397-404. doi: 10.4088/JCP.09m05466yel.

DOI:10.4088/JCP.09m05466yel
PMID:21208588
Abstract

OBJECTIVE

Blockade of dopamine D(2) receptors is thought to mediate the therapeutic effects of antipsychotic medication but may also induce social indifference. As antipsychotic drugs differ in D(2) receptor binding, "tight" and "loose" binding drugs may be hypothesized to differentially affect emotional experience. The present study investigates the differential effects of relatively tight versus looser binding drugs on the experience of emotions in the realm of daily life.

METHOD

We assessed positive and negative affect in the daily life of 109 patients with a DSM-IV diagnosis of psychotic disorder who were currently taking antipsychotic medication by using the experience sampling method (a structured diary technique). Antipsychotic medication was classified as loose (olanzapine; n = 35) or tight (haloperidol, risperidone; n = 74) binding, based on the drug's dissociation constants at the D(2) receptor. The study was conducted from 2007 to 2008.

RESULTS

Multilevel analyses showed a significant interaction between binding group (loose vs tight) and D(2) receptor occupancy estimates with regard to the experience of positive (P = .008) and negative (P = .019) affect. For tight-binding-agent users, a significant association was found between D(2) receptor binding estimates and both positive affect (P = .040) and negative affect (P = .0001) in the flow of daily life, with increasing levels of estimated D(2) receptor occupancy being associated with decreased feelings of positive affect and increased feelings of negative affect. For loose-binding-agent users, no such association was apparent. These associations were only partly mediated by clinical symptoms.

CONCLUSIONS

These findings add ecological validity to previous laboratory findings showing an association between D(2) receptor occupancy and emotional experience.

摘要

目的

多巴胺 D2 受体阻断被认为介导了抗精神病药物的治疗效果,但也可能导致社交冷漠。由于抗精神病药物在 D2 受体结合方面存在差异,因此可以假设“紧密”和“宽松”结合的药物会对情绪体验产生不同的影响。本研究调查了相对紧密和宽松结合的药物在日常生活领域对情绪体验的差异影响。

方法

我们使用经验采样法(一种结构化日记技术)评估了 109 名符合 DSM-IV 精神障碍诊断标准的患者在日常生活中的积极和消极情绪。根据药物在 D2 受体上的解离常数,将抗精神病药物分为松散(奥氮平;n=35)或紧密(氟哌啶醇、利培酮;n=74)结合。研究于 2007 年至 2008 年进行。

结果

多层分析显示,结合组(松散与紧密)和 D2 受体占有率估计值与积极(P=0.008)和消极(P=0.019)情绪体验之间存在显著的相互作用。对于紧密结合药物使用者,D2 受体结合估计值与日常生活中的积极情绪(P=0.040)和消极情绪(P=0.0001)之间存在显著关联,随着 D2 受体占有率的增加,积极情绪的感觉降低,消极情绪的感觉增加。对于松散结合药物使用者,没有出现这种关联。这些关联部分由临床症状介导。

结论

这些发现增加了先前实验室研究的生态有效性,表明 D2 受体占有率与情绪体验之间存在关联。

相似文献

1
Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study.情感体验和抗精神病药物治疗的精神病患者 D2 受体占有率的评估:一项经验抽样研究。
J Clin Psychiatry. 2011 Oct;72(10):1397-404. doi: 10.4088/JCP.09m05466yel.
2
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.低剂量奥氮平或氟哌啶醇治疗近期发病精神分裂症患者的主观体验与D2受体占有率:一项随机双盲研究
Am J Psychiatry. 2003 Feb;160(2):303-9. doi: 10.1176/appi.ajp.160.2.303.
3
A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.一项比较氟哌啶醇、利培酮和奥氮平用于首发非情感性精神病急性治疗的实用性临床试验。
J Clin Psychiatry. 2006 Oct;67(10):1511-21. doi: 10.4088/jcp.v67n1004.
4
Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.奥氮平与氟哌啶醇在精神分裂症程序性学习方面的比较及其与纹状体D2受体占有率的关系
J Neuropsychiatry Clin Neurosci. 2004 Winter;16(1):47-56. doi: 10.1176/jnp.16.1.47.
5
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.从多巴胺D(2)受体的快速解离能否解释非典型抗精神病药物的作用?:一个新假说。
Am J Psychiatry. 2001 Mar;158(3):360-9. doi: 10.1176/appi.ajp.158.3.360.
6
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.氯氮平对多巴胺D1和D2受体的等效占有率:与其他非典型抗精神病药物的区别
Am J Psychiatry. 2004 Sep;161(9):1620-5. doi: 10.1176/appi.ajp.161.9.1620.
7
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.抗精神病药物的不良主观体验及其与纹状体和纹状体外D2受体的关系:一项针对精神分裂症的正电子发射断层扫描研究
Am J Psychiatry. 2007 Apr;164(4):630-7. doi: 10.1176/ajp.2007.164.4.630.
8
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.早期精神病的口服与注射用抗精神病药物治疗:两项研究的事后比较
Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.
9
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.氟哌啶醇、利培酮和奥氮平治疗首发精神病的神经认知有效性:一项随机对照1年随访比较研究
J Clin Psychiatry. 2009 Apr 21;70(5):717-29. doi: 10.4088/JCP.08m04634.
10
Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.非典型抗精神病药物利培酮和奥氮平对多巴胺D2受体的占据:理论意义
Psychopharmacology (Berl). 2004 Oct;175(4):473-80. doi: 10.1007/s00213-004-1852-4.

引用本文的文献

1
Understanding tinnitus symptom dynamics and clinical improvement through intensive longitudinal data.通过密集纵向数据理解耳鸣症状动态变化及临床改善情况。
NPJ Digit Med. 2025 Jan 14;8(1):27. doi: 10.1038/s41746-024-01425-w.
2
Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders.用氨磺必利优化首发精神分裂症或相关障碍患者的主观幸福感。
Psychol Med. 2023 Oct;53(13):5986-5991. doi: 10.1017/S0033291722003142. Epub 2022 Dec 15.
3
Relationship between subjective well-being and aripiprazole: an [C]raclopride PET study.
主观幸福感与阿立哌唑的关系:一项[C]氯丙嗪 PET 研究。
Sci Rep. 2022 Jul 15;12(1):12106. doi: 10.1038/s41598-022-16130-5.
4
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia.长效注射用抗精神病药物在以患者为中心的精神分裂症护理中的现代视角。
Neuropsychiatr Dis Treat. 2019 Apr 30;15:1045-1060. doi: 10.2147/NDT.S199048. eCollection 2019.
5
Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.重新审视精神分裂症中抗精神病药物的主观耐受性概念及其临床和研究意义:30 年后。
CNS Drugs. 2019 Jan;33(1):1-8. doi: 10.1007/s40263-018-0588-3.
6
Experience sampling methodology in mental health research: new insights and technical developments.心理健康研究中的经验抽样法:新见解与技术发展
World Psychiatry. 2018 Jun;17(2):123-132. doi: 10.1002/wps.20513.
7
Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.健康受试者使用抗多巴胺能药物会引发主观和客观的精神损害,这与生物源性单胺代谢和催乳素分泌的紊乱密切相关。
Neuropsychiatr Dis Treat. 2018 Apr 27;14:1125-1138. doi: 10.2147/NDT.S148557. eCollection 2018.
8
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews.鲁拉西酮治疗双相抑郁:系统评价的系统综述
Biomed Res Int. 2017;2017:3084859. doi: 10.1155/2017/3084859. Epub 2017 May 9.
9
Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.初步证据表明,在健康对照者和精神分裂症患者中,阴性症状严重程度与多巴胺信号传导能力和D2受体结合的多位点基因谱相关。
J Psychiatr Res. 2017 Mar;86:9-17. doi: 10.1016/j.jpsychires.2016.11.007. Epub 2016 Nov 17.
10
An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis.一项关于精神病症状与治疗的n=1临床网络分析
PLoS One. 2016 Sep 19;11(9):e0162811. doi: 10.1371/journal.pone.0162811. eCollection 2016.